ARIH2 Ubiquitination Regulates NUPR1 to Inhibit Ferroptosis in Bladder Cancer
Journal of Cellular and Molecular Medicine · 2026
DOI: 10.1111/jcmm.71147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2026. Verfasst von Hannuo Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second People's Hospital of Changzhou, Changzhou Medical Center, Changzhou, China. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Ubiquitination, Urinary Bladder Neoplasms, Ferroptosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Basic Research Project of Changzhou Medical Center, Science and Technology Project of Changzhou Health Commission, Jiangsu Province 333 Project.
Abstract (Originalsprache)
NUPR1 is a pro‐tumorigenic factor in bladder cancer (BLCA), but the mechanisms governing its protein stability remain poorly defined. Here, we identified ARIH2 as an E3 ubiquitin ligase that interacts with NUPR1 in BLCA cells through immunoprecipitation‐mass spectrometry (IP‐MS), co‐immunoprecipitation (Co‐IP), and immunofluorescence analyses. ARIH2 overexpression reduced NUPR1 abundance and inhibited BLCA cell proliferation and migration while enhancing apoptosis, whereas ARIH2 knockdown increased NUPR1 expression and promoted malignant phenotypes. Mechanistically, ARIH2 depletion prolonged NUPR1 protein stability and reduced its ubiquitination, indicating that ARIH2 negatively regulates NUPR1 through ubiquitin‐mediated degradation. Moreover, NUPR1 overexpression suppressed ferroptosis, as reflected by increased GPX4 and SLC7A11, decreased ACSL4, reduced lipid peroxidation, and diminished Fe 2+ accumulation, while NUPR1 knockdown exerted the opposite effects. ARIH2 knockdown mimicked the ferroptosis‐resistant phenotype induced by NUPR1 upregulation, supporting that ARIH2 modulates ferroptosis through NUPR1. Bioinformatic and experimental analyses further showed that NUPR1 was associated with immunosuppressive infiltration and promoted M2 macrophage polarization. Together, our findings uncover an ARIH2–NUPR1 regulatory axis that drives BLCA progression by suppressing ferroptosis and favouring an immunosuppressive microenvironment, highlighting this pathway as a potential therapeutic target in BLCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Second People's Hospital of Changzhou, Changzhou Medical Center, Changzhou, China.
- Department of Urology, Affiliated Hospital of Jiangnan University, Wuxi, China.
- Department of Nursing, Wuxi Huishan District People's Hospital, Wuxi, China.
ORCID-Profile: Yuanyuan Mi, Zebin Shi, Li Zuo
Förderung
- the Basic Research Project of Changzhou Medical Center
- Science and Technology Project of Changzhou Health Commission
- Jiangsu Province 333 Project
- Changzhou Health Committee Youth Science and Technology Program
- Top Talent of Changzhou "The 14th Five-Year Plan" High-Level Health Talents Training Project
- Jiangsu Province Postdoctoral Research Foundation
- Changzhou Sci&Tech Program
- Postdoctoral Science Startup Foundation
Zitieren
APA
Deng, H., Mi, Y., Zhang, L., Tan, Y., He, G., Shi, Z., Gao, S., Zhang, L., Zuo, L., & Peng, J. (2026). ARIH2 Ubiquitination Regulates NUPR1 to Inhibit Ferroptosis in Bladder Cancer. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.71147
Vancouver
Deng H, Mi Y, Zhang L, Tan Y, He G, Shi Z, et al. ARIH2 Ubiquitination Regulates NUPR1 to Inhibit Ferroptosis in Bladder Cancer. Journal of Cellular and Molecular Medicine. 2026. doi:10.1111/jcmm.71147
BibTeX
@article{Deng2026,
author = {Deng, Hannuo and Mi, Yuanyuan and Zhang, Lei and Tan, Yuchen and He, Guangming and Shi, Zebin and Gao, Shenglin and Zhang, Lifeng and Zuo, Li and Peng, Jie},
title = {ARIH2 Ubiquitination Regulates NUPR1 to Inhibit Ferroptosis in Bladder Cancer},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
doi = {10.1111/jcmm.71147}
}
EUVIMED